Speech Series
Speech Series (2010)
June 15, 2010: Barbara Ouellet delivered a presentation, A Responsive Regulator in a
Time of Change, at The Canadian Institute´s 4th Annual Drug Pricing & Reimbursement in Canada (PDF)
May 11, 2010: Greg McComb, Senior Economic Analyst, NPDUIS, gave a presentation, Public Drug Plan Professional Fees: A Cost-Driver Analysis, at the 2010 Annual Conference of CAHSPR (PDF)
May 6, 2010: Barbara Ouellet delivered a presentation, A Modern Regulator for a Changing Industry, at the Drug Patents in Canada conference, in Toronto (PDF)
March 24, 2010: Dr. Benoit delivered a presentation, Canada´s Patented Medicines Prices Review Board, at the Pharma Pricing & Market Access Outlook conference, in London, UK (PDF)
Speech Series (2009)
Outreach Presentation Compendium of Policies, Guidelines and Procedures, June 2009 Implementation: January 1, 2010; October 28, 2009, Montreal; October 29, 2009, Toronto (PDF)
Outreach Presentation on the revised Excessive Price Guidelines (January 2010), June 17, 2009, Toronto; June 18, 2009 Montreal (PPT)
Dr. Benoit delivered a presentation, Canada´s Patented Medicine Prices Review Board Moving Forward with the Board´s Policies and Excessive Price Guidelines, at the 3rd Annual Drug Pricing & Reimbursement in Canada, in Toronto. (PPT)
April 29-30, 2009: Dr. Benoit delivered a presentation, Canada's Patented Medicine Prices Review Board - Moving Forward, at the Pharma Pricing & Market Access Outlook conference in London, UK (PPT)
Speech Series (2008)
December 3: Barbara Ouellet gave a presentation on the PMPRB and the Review of its Excessive Price Guidelines, at the 7th market Access Summit, in Toronto. (PPT)
November 26: Barbara Ouellet gave a presentation on the PMPRB at theProcurement Conference, in Scottsdale, Arizona. (PPT)
June 9, 2008: Sylvie Dupont gave a presentation on the Role and Responsibilities of the PMPRB (Patented Medicine Prices Review Board and Pharmaceutical Price Regulation in Canada), at the MEDIUM Workshop, organized by the Ontario Pharmacists Association. (PPT)
May 22, 2008: Ginette Tognet gave a presentation on the Price Review Process for Patented Medicines at the Post Market Drug Safety and Effectiveness Workshop, University of Ottawa. (PPT)
June 24, 2008: Barbara Ouellet gave a presentation at the Drug Prices and Reimbursement in Canada Conference, in Toronto.(PPT)
April 28-29, 2008: CADTH Invitational Symposium Beyond the Evidence: Making Tough Decisions, held in Edmonton.
Members of the NPDUIS Team made presentation to the symposium:
- Rebecca Szilagyi, MPH, Economist
The New Drug Pipeline Monitor: A New Phase for NPDUIS (PPT)
- Elena Lungu, Senior Economist
The Use of the World Health Organization´s Defined Daily Dose in Drug Cost & Utilization Analyses (PPT)
- Greg McComb, Senior Economist
NPDUIS Drug Trend Report, 2005/06 (PPT)
April 23-24, 2008: Pharmaceutical Pricing Summit, London UK
Dr. Benoit delivered a speech on the mandate of the PMPRB and the challenges of pharmaceutical price regulation.
February 27, 2008: Barbara Ouellet gave a presentation at the Drug Patent Law and Patent Litigation Conference in Toronto (PPT)
February 7, 2008: Introductory Remarks by the Chairperson of the PMPRB to the Standing Committee on Health on the National Prescription Drug Utilization Information System (NPDUIS) in Ottawa. (PDF)
Speech Series (2007)
Market Access Managing Public and Private Reimbursement Challenges Conference, December 4-5, in Toronto.
Ginette Tognet, Director of Compliance and Enforcement gave a presentation on The latest Developments at the Patented Medicine Prices Review Board. (PPT)
Barbara Ouellet, Executive Director gave a presentation on the role and responsibilities of the PMPRB at the 2007 Canadian Drug Information Association Conference Blueprint for an Evolving Regulatory Environment, on October 30, 2007, in Ottawa. (PPT)
The 6th Annual Forum on Pharma Patents, October 18, in Toronto. Barbara Ouellet gave a presentation: Catching Up on the Latest Developments at the PMPRB (PDF) (PPT)
Brogan Advanced Training Seminars
October 3: Montréal
October 4: Toronto
Barbara Ouellet and Ginette Tognet made presentations on the Price review process and on the review of the Board´s Excessive Price Guidelines.
Canadian Institute Drug Pricing and Reimbursement in Canada June 4-5, Toronto
Presentation by Barbara Ouellet, Executive Director of the PMPRB Highlighting the Mandate of the PMPRB and Recent Development in Price Regulation
Janssen Ortho´s Board of Directors Conference April 27, 2007
Presentation, before Janssen Ortho´s Board of Directors, by Barbara Ouellet, Executive Director of the PMPRB - Update from the Patented Medicine Prices Review Board (PPT)
Introductory Remarks by the Chairperson of the PMPRB to the Standing Committee on Health on Main Estimates, March 28, in Ottawa (PDF)
Summit on Pharmaceutical and Biotech Regulatory Compliance - March 26-27, 2007
Presentation by Barbara Ouellet, Executive Director of the PMPRB - Update from the Patented Medicine Prices Review Board (PPT)
Speech Series (2006)
Pharmaceuticals Management and Price Control in Canada, By Barbara Ouellet, Executive Director of the PMPRB at the North America Pharma Summit, March 31, 2006, in Toronto Examining the Flip Side of Drug Safety Affordability, By Barbara Ouellet, Executive Director, PMPRB, at the Drug Safety Summit 2006, Toronto February 20, 2006
Speech Series (2005)
Drug Pricing: Current Trends and Future Directions, Presentation by Barbara Ouellet, Executive Director of the PMPRB, at the Pharmac Sales & Marketing Summit 2005, November 21, in Toronto
Introductory Remarks by the Vice-Chairperson of the PMPRB to the Standing Committee on Health on Main Estimates, April 18, in Ottawa (PDF)
Drug Prices in Canada and the US: More Than Meets the Eye?, Presentation by the Executive Director of the PMPRB at the Annual Conference of the National Academy of Social Insurance, January 27, in Washington, D.C.
Return to Publications